NCT04503655View on ClinicalTrials.gov

Multicenter Study Evaluating the Efficacy of an Intervention Aimed At Reducing the Length of Stay After Transfemoral Transcatheter Aortic Valve Implantation

NACompletedINTERVENTIONAL
Enrollment

1,842

Participants

Timeline

Start Date

December 16, 2020

Primary Completion Date

February 9, 2022

Study Completion Date

February 9, 2022

Conditions
Aortic Valve StenosisCardiovascular Diseases
Interventions
OTHER

Training

"Training dedicated on implementation of organizational and therapeutic measures (for prevention and management of complications) to reduce lenght-of-stay after TF TAVI."

Trial Locations (20)

Unknown

CHU d'Amiens, Amiens

CHU d'Angers, Angers

CHU de Bordeaux, Bordeaux

CHU de Brest, Brest

CHU de Caen, Caen

Hôpital privé Saint Martin, Caen

CHU de Clermont-Ferrand, Clermont-Ferrand

Hôpital Henri Mondor (AP-HP), Créteil

CHU de Dijon, Dijon

CHU de Grenoble, Grenoble

CHU de Limoges, Limoges

Hôpital privé Jacques Cartier, Massy

Clinique du Millénaire, Montpellier

Hôpital Bichat, AP-HP, Paris

Hôpital Européen Georges Pompidou (AP-HP), Paris

CHU de Poitiers, Poitiers

CHU de Strasbourg, Strasbourg

CHU de Toulouse, Toulouse

Clinique Pasteur, Toulouse

Clinique Saint Gatien, Tours

All Listed Sponsors
lead

University Hospital, Rouen

OTHER

NCT04503655 - Multicenter Study Evaluating the Efficacy of an Intervention Aimed At Reducing the Length of Stay After Transfemoral Transcatheter Aortic Valve Implantation | Biotech Hunter | Biotech Hunter